Sort   by:  
 Page size 
UnknownImproving the representativeness of UK's national COVID-19 Infection Survey through spatio-temporal regression and post-stratification.
Not available
S-EPMC11196632 | biostudies-literature
UnknownAntibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom.
Not available
S-EPMC8294260 | biostudies-literature
UnknownTracking the Emergence of SARS-CoV-2 Alpha Variant in the United Kingdom.
Not available
S-EPMC8693687 | biostudies-literature
UnknownAntibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines.
Not available
S-EPMC9117148 | biostudies-literature
UnknownProtection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK.
Not available
S-EPMC10187514 | biostudies-literature
UnknownSARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection.
Not available
S-EPMC9243074 | biostudies-literature
UnknownSymptoms and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity in the General Population in the United Kingdom.
Not available
S-EPMC8767848 | biostudies-literature
UnknownCommunity prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey.
Not available
S-EPMC7786000 | biostudies-literature
UnknownTrial of Erythropoietin for Hypoxic-Ischemic Encephalopathy in Newborns.
Not available
S-EPMC10542745 | biostudies-literature
UnknownIdentification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.
Not available
S-EPMC3709460 | biostudies-literature
Sort   by:  
 Page size